Rezenopy Spray
Product Images NDC 83245-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Rezenopy (NDC 83245-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Scienture Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Rezenopy Naloxone HCl Nasal Spray 1)

Chem Structure (Rezenopy Naloxone HCl Nasal Spray 1)
This is a molecular formula for a compound with a relative molecular mass of 399.87. It consists of carbon, hydrogen, nitrogen, and oxygen, with hydrochloride and water (HCl • 2H2O) as part of the compound. It is likely a complex organic molecule with these elements in its composition.*
FDA Label Image

Figure G (Rezenopy Naloxone HCl Nasal Spray 10)

FDA Label Image

Figure H (Rezenopy Naloxone HCl Nasal Spray 11)

FDA Label Image

Figure I (Rezenopy Naloxone HCl Nasal Spray 12)

FDA Label Image

Figure J (Rezenopy Naloxone HCl Nasal Spray 13)

FDA Label Image

Figure K (Rezenopy Naloxone HCl Nasal Spray 14)

FDA Label Image

Figure L (Rezenopy Naloxone HCl Nasal Spray 15)

FDA Label Image

Figure M (Rezenopy Naloxone HCl Nasal Spray 16)

FDA Label Image

Carton (Rezenopy Naloxone HCl Nasal Spray 17)

Carton (Rezenopy Naloxone HCl Nasal Spray 17)
This text provides important storage information, dosage, and administration details for REZENOPY Nasal Spray. It advises storing the product between 2°C to 25°C (36°F to 77°F) and not exposing it to temperatures above 40°C (104°F). The spray should be protected from light and kept in its package until ready to use. There is a warning to keep it out of reach of children. The Nasal Spray contains naloxone HCI and other inactive ingredients for use in the nose only. The packaging instructions emphasize not removing the spray devices from the blister before use. Pharmacists are instructed to dispense the entire carton as a unit, and users should check the product expiration date before use. Additionally, there is a reference to a quick start guide for easy use.*
FDA Label Image

Figure 1 (Rezenopy Naloxone HCl Nasal Spray 2)

Figure 1 (Rezenopy Naloxone HCl Nasal Spray 2)
This text provides information on Naloxone plasma concentrations at different time intervals after administration. It includes data for Naloxone nasal spray (10mg), intramuscular injection (0.4 mg), and intravenous injection (2 mg). The chart seems to present how the concentration of Naloxone changes over time in the bloodstream.*
FDA Label Image

Figure 2 (Rezenopy Naloxone HCl Nasal Spray 3)

FDA Label Image

Figure A (Rezenopy Naloxone HCl Nasal Spray 4)

Figure A (Rezenopy Naloxone HCl Nasal Spray 4)
This is a list of items related to a fuel pump or a similar mechanical device. The list includes a "Nozzle," a "Plunger," and a reference to "Figure A." It seems to be part of an instructional manual or technical document.*
FDA Label Image

Figure B (Rezenopy Naloxone HCl Nasal Spray 5)

FDA Label Image

Figure C (Rezenopy Naloxone HCl Nasal Spray 6)

FDA Label Image

Figure D (Rezenopy Naloxone HCl Nasal Spray 7)

FDA Label Image

Figure E (Rezenopy Naloxone HCl Nasal Spray 8)

FDA Label Image

Figure F (Rezenopy Naloxone HCl Nasal Spray 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.